Author: Yang Yang; Chenguang Shen; Jinxiu Li; Jing Yuan; Minghui Yang; Fuxiang Wang; Guobao Li; Yanjie Li; Li Xing; Ling Peng; Jinli Wei; Mengli Cao; Haixia Zheng; Weibo Wu; Rongrong Zou; Delin Li; Zhixiang Xu; Haiyan Wang; Mingxia Zhang; Zheng Zhang; Lei Liu; Yingxia Liu
Title: Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome Document date: 2020_3_6
ID: c3dxfet9_19
Snippet: were collected at the earliest time-point after hospitalization. The study protocol was Declaration of Helsinki and institutional ethics guidelines. qRT-PCR were done as previously reported 26, 34 . In brief, throat swabs, nasal swabs, Food and Drug Administration (CDFA) approved commercially kit (GeneoDX Co.,.....
Document: were collected at the earliest time-point after hospitalization. The study protocol was Declaration of Helsinki and institutional ethics guidelines. qRT-PCR were done as previously reported 26, 34 . In brief, throat swabs, nasal swabs, Food and Drug Administration (CDFA) approved commercially kit (GeneoDX Co.,
Search related documents:
Co phrase search for related documents- early time point and time point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- GeneoDX kit and nasal swab: 1
- GeneoDX kit and throat swab: 1
- nasal swab and study protocol: 1, 2, 3, 4
- nasal swab and throat swab: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- nasal swab and time point: 1, 2, 3, 4, 5, 6
- study protocol and throat swab: 1, 2, 3, 4
- study protocol and time point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- throat swab and time point: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date